Bank of New York Mellon’s Minerva Neurosciences NERV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-2,463
| Closed | -$16K | – | 4664 |
|
2022
Q1 | $16K | Hold |
2,463
| – | – | ﹤0.01% | 4623 |
|
2021
Q4 | $16K | Hold |
2,463
| – | – | ﹤0.01% | 4596 |
|
2021
Q3 | $34K | Sell |
2,463
-1,382
| -36% | -$19.1K | ﹤0.01% | 4473 |
|
2021
Q2 | $71K | Sell |
3,845
-11,199
| -74% | -$207K | ﹤0.01% | 4268 |
|
2021
Q1 | $352K | Sell |
15,044
-231
| -2% | -$5.41K | ﹤0.01% | 3845 |
|
2020
Q4 | $286K | Buy |
15,275
+1,330
| +10% | +$24.9K | ﹤0.01% | 3846 |
|
2020
Q3 | $355K | Sell |
13,945
-99
| -0.7% | -$2.52K | ﹤0.01% | 3647 |
|
2020
Q2 | $406K | Buy |
14,044
+1,664
| +13% | +$48.1K | ﹤0.01% | 3576 |
|
2020
Q1 | $597K | Sell |
12,380
-191
| -2% | -$9.21K | ﹤0.01% | 3259 |
|
2019
Q4 | $715K | Sell |
12,571
-2,871
| -19% | -$163K | ﹤0.01% | 3397 |
|
2019
Q3 | $957K | Sell |
15,442
-484
| -3% | -$30K | ﹤0.01% | 3197 |
|
2019
Q2 | $717K | Sell |
15,926
-988
| -6% | -$44.5K | ﹤0.01% | 3415 |
|
2019
Q1 | $1.06M | Buy |
16,914
+211
| +1% | +$13.3K | ﹤0.01% | 3132 |
|
2018
Q4 | $900K | Buy |
16,703
+848
| +5% | +$45.7K | ﹤0.01% | 3165 |
|
2018
Q3 | $1.59M | Buy |
15,855
+2,882
| +22% | +$289K | ﹤0.01% | 2985 |
|
2018
Q2 | $857K | Sell |
12,973
-85
| -0.7% | -$5.62K | ﹤0.01% | 3333 |
|
2018
Q1 | $652K | Sell |
13,058
-836
| -6% | -$41.7K | ﹤0.01% | 3440 |
|
2017
Q4 | $672K | Sell |
13,894
-1,250
| -8% | -$60.5K | ﹤0.01% | 3454 |
|
2017
Q3 | $921K | Buy |
15,144
+3,778
| +33% | +$230K | ﹤0.01% | 3268 |
|
2017
Q2 | $805K | Buy |
11,366
+1,341
| +13% | +$95K | ﹤0.01% | 3374 |
|
2017
Q1 | $649K | Buy |
10,025
+161
| +2% | +$10.4K | ﹤0.01% | 3448 |
|
2016
Q4 | $927K | Buy |
9,864
+2,469
| +33% | +$232K | ﹤0.01% | 3300 |
|
2016
Q3 | $835K | Buy |
7,395
+1,004
| +16% | +$113K | ﹤0.01% | 3267 |
|
2016
Q2 | $523K | Buy |
+6,391
| New | +$523K | ﹤0.01% | 3517 |
|